{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:42:20Z","timestamp":1791848540774,"version":"4.3.4"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T00:00:00Z","timestamp":1427414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.virol.2015.03.032","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T00:36:11Z","timestamp":1428712571000},"page":"379-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":458,"special_numbering":"C","title":["Live attenuated vaccines: Historical successes and current challenges"],"prefix":"10.1016","volume":"479-480","author":[{"given":"Philip D.","family":"Minor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2015.03.032_bib1","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0022-3476(09)90015-4","volume":"122","author":"Aaby","year":"1993","journal-title":"J. Pediatr."},{"key":"10.1016\/j.virol.2015.03.032_bib2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1099\/0022-1317-74-5-917","article-title":"The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates","volume":"74","author":"Afzal","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib3","first-page":"1813","article-title":"Immune response and vaccine efficacy","volume":"17","author":"Afzal","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.03.032_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/biol.1999.0174","article-title":"Evaluation of the neurovirulence test for mumps vaccines","volume":"27","author":"Afzal","year":"1999","journal-title":"Biologicals"},{"issue":"Suppl. 2","key":"10.1016\/j.virol.2015.03.032_bib5","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.mp.4001180","article-title":"Vaccines, Crohn\u05f3s disease and autism","volume":"7","author":"Afzal","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.virol.2015.03.032_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jviromet.2005.01.032","article-title":"Assessment of mumps virus growth on various continuous cell lines by virological immunological, molecular and morphological investigations","volume":"126","author":"Afzal","year":"2005","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2015.03.032_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jmv.20585","article-title":"Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK","volume":"78","author":"Afzal","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib8","first-page":"144","article-title":"Mumps caused by an inadequately attenuated measles, mumps and rubella vaccine","volume":"12","author":"Bakker","year":"2001","journal-title":"Can. J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/rmv.1980050406","article-title":"Complications of mumps vaccines","volume":"5","author":"Balraj","year":"1995","journal-title":"Rev. Med. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2015.03.032_bib10","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1093\/infdis\/jir097","article-title":"Genetic characterization of measles vaccine strains","volume":"204","author":"Bankamp","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib11","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1099\/0022-1317-71-10-2301","article-title":"Attenuation of wild type yellow fever virus by passage in HeLa cells","volume":"71","author":"Barrett","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine \u2013 how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"Barrett","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virol.2015.03.032_bib13","series-title":"Small Pox Vaccine, Ahead of its Time","author":"Baxby","year":"2001"},{"key":"10.1016\/j.virol.2015.03.032_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/rmv.361","article-title":"Classic paper: studies in smallpox and vaccination","volume":"12","author":"Baxby","year":"2002","journal-title":"Rev. Med Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-1157(89)90031-0","article-title":"Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials","volume":"17","author":"Beck","year":"1989","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.virol.2015.03.032_bib16","unstructured":"Beijerinck, M.W., 1898 [1968]. Concerning a contagium vivum fluidum as cause of the spot disease of tobacco leaves. In: Johnson, J. (translator\/editor), Phytopathological Classics, Number 7. American Phytopathological Society, St. Paul, MN, pp. 33\u201352."},{"key":"10.1016\/j.virol.2015.03.032_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.122.3159.105","article-title":"Emerging concept of poliomyelitis infection","volume":"122","author":"Bodian","year":"1955","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.032_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0928-0197(95)00159-X","article-title":"Detection of reverse transcriptase in live attenuated virus vaccines","volume":"5","author":"Boni","year":"1996","journal-title":"Clin. Diag. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0092-1157(79)80042-6","article-title":"Comparative neurovirulence of Sabin type 3 polio virus vaccines","volume":"7","author":"Boulger","year":"1979","journal-title":"J. Biol. Stand."},{"issue":"6","key":"10.1016\/j.virol.2015.03.032_bib21","article-title":"An increase in the number of mumps cases in the Czech Republic, 2005, 2006","volume":"13","author":"Boxall","year":"2008","journal-title":"EuroSurveillance"},{"key":"10.1016\/j.virol.2015.03.032_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1099-1654(199807\/09)8:3<129::AID-RMV213>3.0.CO;2-Z","article-title":"Genetic studies on a mumps vaccine strain associated with meningitis","volume":"8","author":"Brown","year":"1998","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib23","first-page":"460","volume":"103","author":"Buynak","year":"1962","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.virol.2015.03.032_bib24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3181\/00379727-123-31599","article-title":"Live attenuated mumps virus vaccine 1. Vaccine development","volume":"123","author":"Buynak","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0042-6822(88)90113-4","article-title":"Intertypic genomic rearrangement of poliovirus vaccine strains in vaccinnees","volume":"157","author":"Cammack","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.032_bib26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2015.03.032_bib27","first-page":"2467","article-title":"Mumps outbreak in a highly vaccinated school population","volume":"263","author":"Cheek","year":"1995","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.virol.2015.03.032_bib28","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titres","volume":"162","author":"Chen","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/1045-1056(90)90009-O","article-title":"Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus","volume":"18","author":"Christenson","year":"1990","journal-title":"Biologicals"},{"key":"10.1016\/j.virol.2015.03.032_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1073\/pnas.88.1.199","article-title":"Correlation between amount of virus with altered nucleotide sequence and the monkey test for the acceptability of oral poliovirus vaccine","volume":"88","author":"Chumakov","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.032_bib31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/jvi.66.2.966-970.1992","article-title":"RNA sequence variants and their relation to neurovirulence","volume":"66","author":"Chumakov","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib32","first-page":"143","article-title":"The work of the WHO consultative group on poliomyelitis vaccines","volume":"66","author":"Cockburn","year":"1988","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.virol.2015.03.032_bib33","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0264-410X(01)00438-8","article-title":"Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad Zagreb mumps strain","volume":"20","author":"da Cunha","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.03.032_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(86)91643-0","article-title":"Failure of live attenuated rotavirus vaccine","author":"De Mol","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2015.03.032_bib35","first-page":"217","article-title":"Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003","volume":"11","author":"Deshpande","year":"2003","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.virol.2015.03.032_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00002018-199819060-00002","article-title":"Measles vaccines: a review of adverse events","volume":"19","author":"Duclos","year":"1998","journal-title":"Drug Saf."},{"key":"10.1016\/j.virol.2015.03.032_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jmv.1890320205","article-title":"Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources","volume":"32","author":"Dunn","year":"1990","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib38","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1093\/nar\/17.10.3989","article-title":"Nucleotide sequence comparison of the genomes of two 17D-204 yellow fever vaccines","volume":"17","author":"Dupuy","year":"1989","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.virol.2015.03.032_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3181\/00379727-86-21073","article-title":"Propagation in tissue culture of cytopayhognic agents from patients with measles","volume":"86","author":"Enders","year":"1954","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib40","first-page":"2941","article-title":"Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil","volume":"25","author":"Engel","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.03.032_bib41","first-page":"195","article-title":"Collaborative study to assess the suitability of a candidate","volume":"32","author":"Ferguson","year":"2004","journal-title":"Int. Stand. Yellow Fever Vaccine Biol."},{"key":"10.1016\/j.virol.2015.03.032_bib42","first-page":"117","article-title":"Encephalitis in man following vaccination with 17D yellow fever virus","volume":"36","author":"Fox","year":"1942","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.virol.2015.03.032_bib43","first-page":"152","article-title":"Behavior of 17D yellow fever virus in rhesus monkeys. Relation to substrain dose, and neural or extraneural inoculation","volume":"38","author":"Fox","year":"1943","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.virol.2015.03.032_bib44","first-page":"77","article-title":"The yellow fever vaccine: a history","volume":"83","author":"Frierson","year":"2010","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib45","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4161\/hv.6.11.12847","article-title":"Effectiveness of Lanzhou lamb rotavirus vaccine against hospitalized gastroenteritis: further analysis and update","volume":"6","author":"Fu","year":"2010","journal-title":"Hum. Vaccines"},{"key":"10.1016\/j.virol.2015.03.032_bib46","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jama.1967.03130250057008","article-title":"Altered reactivity to measles virus: atypical measles in children previous immunized with inactivated measles virus vaccines","volume":"202","author":"Fulginiti","year":"1967","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.virol.2015.03.032_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.1980.03310080038022","article-title":"Atypical measles in adolescent siblings 16 years after killed measles vaccine","volume":"244","author":"Fulginiti","year":"1980","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.virol.2015.03.032_bib48","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0264-410X(97)00278-8","article-title":"Genetic variability among yellow fever virus 17D substrains","volume":"16","author":"Galler","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.03.032_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biologicals.2012.09.007","article-title":"Vaccine-related mumps infections in Thailand and the identification of a novel mutation in the mumps fusion protein","volume":"41","author":"Gilliland","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.virol.2015.03.032_bib50","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1086\/431504","article-title":"Rotavirus vaccines: targeting the developing world","volume":"192","author":"Glass","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib51","first-page":"29","article-title":"Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells","volume":"65","author":"Gluck","year":"1986","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.virol.2015.03.032_bib52","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(99)02853-6","article-title":"Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain","volume":"354","author":"Goh","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2015.03.032_bib53","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","article-title":"Comparison of the virulent asibi strain of yellow fever virus with the 17D vaccine strain derived from it","volume":"84","author":"Hahn","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2015.03.032_bib54","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3181\/00379727-119-30167","article-title":"Loss in virulence of yellow fever virus serially passaged in HeLa cells","volume":"119","author":"Hearn","year":"1965","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jama.1968.03150030043009","article-title":"Development and evaluation of the Moraten measles virus vaccine","volume":"206","author":"Hilleman","year":"1968","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.virol.2015.03.032_bib56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/clinids\/5.3.495","article-title":"Measles vaccines used in Japan","volume":"5","author":"Hirayama","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib57","unstructured":"Ikic, D., Beck, M., Iuzbasic, M., 1970. Characterization of Edmonston\u2013Zagreb measles virus. In: Proceedings of the Symposium on Human Diolois Cells. Yugosalv Academy of Sciences and Arts, Zagreb, pp. 121\u2013129."},{"key":"10.1016\/j.virol.2015.03.032_bib58","first-page":"175","article-title":"Attenuation and characterization of Edmonston\u2013Zagreb measles virus","volume":"16","author":"Ikic","year":"1972","journal-title":"Ann. Immunol. Hung."},{"key":"10.1016\/j.virol.2015.03.032_bib59","first-page":"1909","article-title":"Bartleby Jenner E (1749\u20131823): the three original publications on vaccination against smallpox","author":"Jenner","year":"1798","journal-title":"Harv. Class."},{"key":"10.1016\/j.virol.2015.03.032_bib60","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/169.3.512","article-title":"Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis","volume":"169","author":"Jennings","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib61","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00705-005-0563-4","article-title":"Proposal for genetic characterisation of wildtype mumps strains: preliminary standardisation of the nomenclature","volume":"150","author":"Jin","year":"2005","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.59.1.1","article-title":"An investigation of the etiology of mumps","volume":"59","author":"Johnson","year":"1934","journal-title":"J. Exp. Med."},{"issue":"16","key":"10.1016\/j.virol.2015.03.032_bib63","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.16.18843-en","article-title":"Transmission of the L-Zagreb mumps vaccine virus Croatia, 2005\u20132008","volume":"13","author":"Kaic","year":"2008","journal-title":"EuroSurveillance"},{"key":"10.1016\/j.virol.2015.03.032_bib64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.032_bib65","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1968","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2015.03.032_bib66","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1128\/jvi.64.2.700-705.1990","article-title":"Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus","volume":"64","author":"Kobune","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib67","first-page":"315","article-title":"Non human primate models of measles","volume":"46","author":"Kobune","year":"1996","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.virol.2015.03.032_bib68","first-page":"377","article-title":"U\u00a8 bertragung der Poliomyelitis acuta auf Affen","volume":"2","author":"Landsteiner","year":"1909","journal-title":"Z. Immunitaetsforsch. Exp. Ther."},{"key":"10.1016\/j.virol.2015.03.032_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3181\/00379727-36-9095P","article-title":"Propagation of variola virus in the developing egg","volume":"36","author":"Lazarus","year":"1937","journal-title":"Proc. Soc. Exp. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib70","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0042-6822(91)90877-E","article-title":"The 5\u2032 noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity","volume":"181","author":"Macadam","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.032_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/viro.1993.1003","article-title":"Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates","volume":"192","author":"Macadam","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.032_bib72","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1128\/JVI.00370-06","article-title":"Rational design of genetically stable, live attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication","volume":"80","author":"Macadam","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib73","first-page":"72","article-title":"Hypogammaglobulinaemai in the United Kingdom, VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemai","volume":"310","author":"MacCallum","year":"1971","journal-title":"Spec. Rep. Ser. Med. Res. Counc."},{"key":"10.1016\/j.virol.2015.03.032_bib74","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(04)16150-3","article-title":"Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man","volume":"363","author":"MacLennan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2015.03.032_bib75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bmj.2.2166.40","article-title":"Smallpox in Glasgow 1900\u20131902","author":"McVail","year":"1902","journal-title":"Br. Med. J."},{"key":"10.1016\/j.virol.2015.03.032_bib76","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/clinids\/5.3.504","article-title":"Development and characteristics of live AIK-C measles virus vaccine: a brief report","volume":"5","author":"Makino","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib77","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0092-1157(80)80008-4","article-title":"Monkey neurovirulence of live, attenuated (Sabin) type I and type II poliovirus vaccines","volume":"8","author":"Marsden","year":"1980","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.virol.2015.03.032_bib78","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0264-410X(94)00086-3","article-title":"Antibodies to measle mumps and rubella in UK children 4 years aftervaccination with different MMR vaccines","volume":"13","author":"Miller","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.03.032_bib79","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/jvi.34.1.73-84.1980","article-title":"Comparative biochemical studies of type 3 poliovirus","volume":"34","author":"Minor","year":"1980","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib80","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1099\/0022-1317-73-12-3065","article-title":"The molecular biology of poliovaccines","volume":"73","author":"Minor","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib81","series-title":"Viral Pathogenesis","first-page":"555","article-title":"Poliovirus","author":"Minor","year":"1997"},{"key":"10.1016\/j.virol.2015.03.032_bib82","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biologicals.2011.04.001","article-title":"Neurovirulence tests of three 17D yellow fever vaccine strains","volume":"39","author":"Minor","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.virol.2015.03.032_bib83","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1586\/erv.12.23","article-title":"Considerations for setting the specifications of vaccines","volume":"11","author":"Minor","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2015.03.032_bib84","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1099\/vir.0.036988-0","article-title":"The polio eradication programme and issues of the endgame","volume":"93","author":"Minor","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib85","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1099\/0022-1317-67-4-693","article-title":"Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccine","volume":"67","author":"Minor","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib86","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1099\/0022-1317-70-5-1117","article-title":"The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3","volume":"70","author":"Minor","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib87","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVaxTM: recombinant live attenuated vaccines against flavivirus infections","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.03.032_bib88","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.biocel.2004.01.019","article-title":"Measles: immune suppression and immune responses","volume":"36","author":"Moss","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"Suppl.","key":"10.1016\/j.virol.2015.03.032_bib89","first-page":"S50","article-title":"The 2001 serological surey in the Czech Republic-mumps","volume":"11","author":"Mrazova","year":"2003","journal-title":"Cent. Eur. Piblic Health"},{"key":"10.1016\/j.virol.2015.03.032_bib90","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/oxfordjournals.aje.a120561","article-title":"Antigenic segregation of type 3 poliovirus isolates realted and unrelated to Sabin\u05f3s vaccine strain with the use of modified Wecker and McBride techniques","volume":"83","author":"Nakano","year":"1966","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2015.03.032_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(08)00001-8","article-title":"The pathogenesis of poliomyelitis: what we don\u05f3t know","volume":"71","author":"Nathanson","year":"2008","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2015.03.032_bib92","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1987.03390100073029","article-title":"Vaccine associated paralytic poliomyelitis in the United States:1973 through 1984","volume":"257","author":"Nkowane","year":"1987","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.virol.2015.03.032_bib93","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/infdis\/132.3.262","article-title":"Difference in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus","volume":"132","author":"Norrby","year":"1975","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib94","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0042-6822(81)90448-7","article-title":"Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans","volume":"108","author":"Nottay","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.032_bib95","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/jvi.58.2.348-358.1986","article-title":"Genetic analysis of the attenuation phenotype of poliovirus type 1","volume":"58","author":"Omata","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib96","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1099\/vir.0.052449-0","article-title":"Assessment of the ferret as an in vivo model for mumps virus infection","volume":"94","author":"Parker","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib97","series-title":"A History of Poliomyelitis","author":"Paul","year":"1971"},{"key":"10.1016\/j.virol.2015.03.032_bib98","first-page":"183","article-title":"Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies","volume":"84","author":"Pastoret","year":"1995","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.virol.2015.03.032_bib99","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4269\/ajtmh.2005.72.339","article-title":"Immunogencity and safety of Berna YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial","volume":"72","author":"Pfister","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2015.03.032_bib100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-0934(99)00019-1","article-title":"Assay of humoral immunity to mumps virus","volume":"79","author":"Pipkin","year":"1999","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2015.03.032_bib101","first-page":"165","article-title":"The safety and use of canarypox vectored vaccines","volume":"84","author":"Plotkin","year":"1995","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.virol.2015.03.032_bib102","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/9473","article-title":"Production of atypical measles in rhesus macaque: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody","volume":"5","author":"Polack","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib103","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1086\/587993","article-title":"Safety and aimmunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag\/pol\/nef vaccine in healthy adults","volume":"46","author":"Priddy","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib104","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.032_bib105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/biol.1996.0037","article-title":"Reverse transcriptase activity in vaccines derived from chick cell","volume":"24","author":"Robertson","year":"1996","journal-title":"Biologicals"},{"key":"10.1016\/j.virol.2015.03.032_bib106","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/428098","article-title":"The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study","volume":"191","author":"Rubin","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib107","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.99.6.551","article-title":"Studies of variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunological types","volume":"99","author":"Sabin","year":"1954","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib108","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.99.6.551","article-title":"The natural history of human poliomyelitis. I. Distribution of virus in nervous and non-nervous tissues","volume":"99","author":"Sabin","year":"1941","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib109","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.123.3209.1151","article-title":"Pathogenesis of poliomyelitis: reappraisal in the light of new data","volume":"123","author":"Sabin","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.03.032_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00221337","article-title":"Measles killer of millions in developing countries: strategy for rapid elimination and continuing control","volume":"7","author":"Sabin","year":"1991","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.virol.2015.03.032_bib111","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0092-1157(73)90048-6","article-title":"History of Sabin attenuated poliovirus oral live vaccine strains","volume":"1","author":"Sabin","year":"1973","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.virol.2015.03.032_bib112","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jama.1953.13.1081","article-title":"Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress","volume":"151","author":"Salk","year":"1953","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.virol.2015.03.032_bib113","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-1702(94)00076-O","article-title":"Complete nucleotide sequence of yellow ever virus vaccine strains 17DD and 17D 213","volume":"35","author":"Santos","year":"1995","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2015.03.032_bib114","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/rmv.448","article-title":"Global Distribution of rotavirus serotypes\/genotypes and its implication for the development and implementation of an effective rotavirus vaccine","volume":"15","author":"Santos","year":"2005","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2006.01.035","article-title":"Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity","volume":"350","author":"Sauder","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.032_bib116","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0264-410X(98)80019-4","article-title":"Immune response and vaccine efficacy","volume":"16","author":"Schlegel","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.03.032_bib117","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0042-6822(92)90552-Z","article-title":"Subacute sclerosing panencephalitis is typically characterized by altertions in the fusion protein cytoplasmic domain of the persisting measles virus","volume":"188","author":"Schmid","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.032_bib118","first-page":"386","article-title":"Preliminary tests of a highly attenuated measles vaccine","volume":"103","author":"Schwarz","year":"1962","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.virol.2015.03.032_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.aje.a112197","article-title":"Human exposure to SV40: review and comment","volume":"103","author":"Shah","year":"1976","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2015.03.032_bib120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1469-0691.2010.03121.x","article-title":"No demonstrable association between the Leningrad-Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt","volume":"16","author":"Sharma","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.virol.2015.03.032_bib121","first-page":"201","article-title":"Clinical and immunological response to live tissue culture vaccine against measles","volume":"4","author":"Smorodintsev","year":"1960","journal-title":"Acta Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib122","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0042-6822(90)90190-3","article-title":"Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472AU","volume":"175","author":"Svitkin","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.virol.2015.03.032_bib123","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1128\/jvi.66.5.3194-3197.1992","article-title":"A mutation present in the amino terminus of Sabin 3 poliovirus VP1 Protein is attenuating","volume":"66","author":"Tatem","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib124","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever vaccine virus modified by in vitro cultivation for human immunization","volume":"31","author":"Theiler","year":"1937","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib125","first-page":"111","article-title":"Studies on further attenuated live measle vaccine. I. Adaptation of measles virus to the chorioallantoic membrane of chick embryo and clinical tests on the strain","volume":"13","author":"Ueda","year":"1970","journal-title":"Biken J."},{"key":"10.1016\/j.virol.2015.03.032_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(84)92323-7","article-title":"Protection of infants against rotavirus diarrhea by RIT 4237 attenuated bovine rotavirus strain vaccine","author":"Vesikari","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2015.03.032_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/170.2.443","article-title":"Viral replication and development of specific immunity in macaques after infection with different measles virus strains","volume":"170","author":"van Binnendijk","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.03.032_bib127","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nm.f.1759","article-title":"Non human primate models and the failure of the Merck HIV-1 vaccine in humans","volume":"14","author":"Watkins","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2015.03.032_bib128","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/jvi.63.3.1338-1344.1989","article-title":"Genetic basis of attenuation of the Sabin type 3 oral poliovaccine","volume":"63","author":"Westrop","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.03.032_bib129","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.vaccine.2009.07.082","article-title":"Viscerotropic disease following yellow fever vaccination in Peru","volume":"27","author":"Whittembury","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.03.032_bib130","unstructured":"WHO, 1966. Requirements for the Production and Quality Control of Smallpox Vaccines (Requirements for Biological Substances No. 5) Revised 1965. In: Technical Report Series 323 Annex 4. WHO, Geneva, Switzerland."},{"key":"10.1016\/j.virol.2015.03.032_bib131","first-page":"925","article-title":"Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use with special reference to type 3 poliovirus","volume":"40","author":"WHO","year":"1969","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.virol.2015.03.032_bib132","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-1157(81)80021-2","article-title":"Markers of poliovirus strains isolated form cases temporally associated with the use of live poliovirus vaccine: reprt on a WHO collaborative study","volume":"9","author":"WHO Report","year":"1981","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.virol.2015.03.032_bib133","unstructured":"WHO, 1983. Requirements for Poliomyelitis Vaccine (Oral) (Revised 1982). Technical Report Series 687, pp. 107\u2013174."},{"key":"10.1016\/j.virol.2015.03.032_bib134","unstructured":"WHO, 1988. WHA41.28 Global Eradication of Poliomyelitis by the Year 2000. \u3008www.who.int\u3009 (last accessed 27.11.14)."},{"key":"10.1016\/j.virol.2015.03.032_bib135","unstructured":"WHO, 2002. Guidelines for the Production and Quality Control of Live Attenuated Japanese Encephalitis Vaccine. Technical Report Series 910 Annex 3."},{"key":"10.1016\/j.virol.2015.03.032_bib136","unstructured":"WHO, 2003. Recommendations for the Production and Quality Control of Smallpox Vaccines Revised 2003. In: Technical Report Series 926 Annex 1. WHO, Geneva, Switzerland."},{"key":"10.1016\/j.virol.2015.03.032_bib137","unstructured":"WHO, 2005. Guidelines for the production and quality control of candidate tetravalent dengue virus vaccines (live). Technical Report Series 932 Annex 1, pp. 43\u201372."},{"key":"10.1016\/j.virol.2015.03.032_bib138","unstructured":"WHO, 2007. Guidelines to Assure the Quality Safety and Efficacy of Live Attenuated Rotavirus Vaccine (oral). Technical Report Series 941, Annex 3, pp. 133\u2013187."},{"key":"10.1016\/j.virol.2015.03.032_bib139","unstructured":"WHO, 2010. Recommendations to Assure the Quality, Safety and Efficacy of Live Attenuated Yellow Fever Vaccines. Technical Report Series 978 Annex 5, pp. 241\u2013314."},{"key":"10.1016\/j.virol.2015.03.032_bib140","unstructured":"WHO, 2012. Recommendations to Assure the Quality, Safety and Efficacy of Poliomyelitis Vaccines (oral, live, attenuated) Appendix 2 In Vivo Tests for Neurovirulence and Considerations in Relation to Assay choice. 63rd Report Expert Committee on Biogical Standardization Annex 2; Technical Report Series 980, pp. 108\u2013113."},{"key":"10.1016\/j.virol.2015.03.032_bib141","unstructured":"WHO, 2014a. Poliomyelitis. \u3008http:\/\/www.who.int\/polioeradication.org\u3009 (last accessed 10.12.14)."},{"key":"10.1016\/j.virol.2015.03.032_bib142","unstructured":"WHO, 2014b. Questions and Answers on Dengue Vaccines: Phase III study of CYD-TDV. \u3008http:\/\/www.who.int\/immunization\/research\/development\/WHO_dengue_vaccine_QA_July2014.pdf?ua=1\u3009 (last accessed 10.12.14)."},{"key":"10.1016\/j.virol.2015.03.032_bib143","unstructured":"WHO, 2014c. Questions and Answers on Dengue Vaccines: Phase III Study of CYD-TDV. \u3008http:\/\/www.who.int\/immunization\/research\/development\/QA_Dengue_vaccine_LA_phIIIstudy_final.pdf?ua=1\u3009 (last accessed 10.12.14)."},{"key":"10.1016\/j.virol.2015.03.032_bib144","first-page":"157","article-title":"Studies on live mumps virus vaccineIII Evaluation of newly developed live mumps vorus vaccine","volume":"13","author":"Yamanishi","year":"1970","journal-title":"Biken J."},{"key":"10.1016\/j.virol.2015.03.032_bib145","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1099\/0022-1317-77-10-2491","article-title":"Antigenic and genetic variation of the HN protein of mumps virus strains","volume":"77","author":"Yates","year":"1996","journal-title":"J. Gen. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215001725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215001725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:43:13Z","timestamp":1758588193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682215001725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":145,"alternative-id":["S0042682215001725"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2015.03.032","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live attenuated vaccines: Historical successes and current challenges","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2015.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}